SMARCAL1: a new target for taming tumor immune evasion

被引：0
|
作者：
Xiao, Ting [1 ]
Li, Shiqi [1 ]
Long, Xinghua [1 ]
机构：
[1] Wuhan Univ, Dept Lab Med, Zhongnan Hosp, Wuhan, Peoples R China
来源：
MEDCOMM | 2024年 / 5卷 / 09期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1002/mco2.730
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
    Leuzzi, Giuseppe
    Vasciaveo, Alessandro
    Taglialatela, Angelo
    Chen, Xiao
    Firestone, Tessa M.
    Hickman, Allison R.
    Mao, Wendy
    Thakar, Tanay
    Vaitsiankova, Alina
    Huang, Jen-Wei
    Cuella-Martin, Raquel
    Hayward, Samuel B.
    Kesner, Jordan S.
    Ghasemzadeh, Ali
    Nambiar, Tarun S.
    Ho, Patricia
    Rialdi, Alexander
    Hebrard, Maxime
    Li, Yinglu
    Gao, Jinmei
    Gopinath, Saarang
    Adeleke, Oluwatobi A.
    Venters, Bryan J.
    Drake, Charles G.
    Baer, Richard
    Izar, Benjamin
    Guccione, Ernesto
    Keogh, Michael-Christopher
    Guerois, Raphael
    Sun, Lu
    Lu, Chao
    Califano, Andrea
    Ciccia, Alberto
    CELL, 2024, 187 (04) : 861 - 881.e32
  • [2] SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
    Leuzzi, Giuseppe
    Vasciaveo, Alessandro
    Taglialatela, Angelo
    Chen, Xiao
    Firestone, Tessa M.
    Hickman, Allison R.
    Mao, Wendy
    Thakar, Tanay
    Vaitsiankova, Alina
    Huang, Jen-Wei
    Cuella-Martin, Raquel
    Hayward, Samuel B.
    Kesner, Jordan S.
    Ghasemzadeh, Ali
    Nambiar, Tarun S.
    Ho, Patricia
    Rialdi, Alexander
    Hebrard, Maxime
    Li, Yinglu
    Gao, Jinmei
    Gopinath, Saarang
    Adeleke, Oluwatobi A.
    Venters, Bryan
    Drake, Charles G.
    Baer, Richard
    Izar, Benjamin
    Guccione, Ernesto
    Keogh, Michael-Christopher
    Guerois, Raphael
    Sun, Lu
    Lu, Chao
    Califano, Andrea
    Ciccia, Alberto
    CANCER RESEARCH, 2024, 84 (01)
  • [3] SMARCAL1 and replication stress An explanation for SIOD?
    Bansbach, Carol E.
    Boerkoel, Cornelius F.
    Cortez, David
    NUCLEUS-AUSTIN, 2010, 1 (03): : 245 - 248
  • [4] SMARCAL1 is a novel candidate therapeutic target for ALT-positive osteosarcoma
    Taglialatela, Angelo
    Chen, Xiao
    Khan, Zahra Fatema
    Dela Cruz, Filemon
    Shivi, Dua
    Oswald, Dillon
    Benura, Azeroglu
    Denchi, Eros Lazzerini
    Jaewon, Min
    Kung, Andrew L.
    Ciccia, Alberto
    CANCER RESEARCH, 2024, 84 (01)
  • [5] Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment
    Jiang, Yuanyuan
    Li, Shuchang
    Ramesh, Rajagopal
    CANCER LETTERS, 2024, 592
  • [6] Identification and Characterization of SMARCAL1 Protein Complexes
    Betous, Remy
    Glick, Gloria G.
    Zhao, Runxiang
    Cortez, David
    PLOS ONE, 2013, 8 (05):
  • [7] SMARCAL1 is a novel synthetic lethal target in ALT plus osteosarcoma and neuroblastoma
    Wierdl, Monika
    Catlett, Jerrel L.
    Ocasio-Martinez, Nicole
    Johnson, Jon D.
    Herman, Amy
    Dharia, Neekesh V.
    Alexe, Gabriela
    Sweet-Cordero, E. Alejandro
    Bernstein, Emily
    Stegmaier, Kimberly
    Guenther, Lillian M.
    CANCER RESEARCH, 2024, 84 (06)
  • [8] SMARCAL1 and telomeres: Replicating the troublesome ends
    Poole, Lisa A.
    Cortez, David
    NUCLEUS, 2016, 7 (03) : 270 - 274
  • [9] On the Interaction Between SMARCAL1 and BRG1
    Bisht, Deepa
    Patne, Ketki
    Rakesh, Radhakrishnan
    Muthuswami, Rohini
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [10] Profound synthetic lethality between SMARCAL1 and FANCM
    Feng, Sumin
    Liu, Kaiwen
    Shang, Jinfeng
    Hoeg, Lisa
    Pastore, Graziana
    Yang, William
    Roy, Sabrina
    Sastre-Moreno, Guillermo
    Young, Jordan T. F.
    Wu, Wei
    Xu, Dongyi
    Durocher, Daniel
    MOLECULAR CELL, 2024, 84 (23)
12345